CELLINK - About the company
CELLINK is a public company based in Boston (United States), founded in 2016 by Erik Gatenholm, Hector Martinez and Gusten Danielsson. It operates as a Developer of 3D bioprinters and bioinks for research purposes. CELLINK has raised an undisclosed amount in funding. The company has 87 active competitors, including 24 funded and 12 that have exited. Its top competitors include companies like Aspect Biosystems, Cyfuse and Allevi.
Company Details
Developer of 3D bioprinters and bioinks for research purposes. It designs and develops 3D bioprinters for cell culture, tissue engineering, and drug development applications. The company also offers single-cell dispensers, liquid handlers, bioreactors, live-cell analyzers, omics, NGS reagents, bio-inks, biomaterials, and other consumables.
- Website
- www.cellink.com
- Social
- Email ID
- *****@cellink.com
- Phone Number
- +1 **********
- Part Of
- BICO
- Registered Address
- Komenského 212 68323 Ivanovice na Hané
Key Metrics
Founded Year
2016
Location
Boston, United States
Stage
Public
Latest Funding Round
Investors
Ranked
6th among 87 active competitors
Employee Count
65 as on Dec 31, 2022
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with CELLINK
CELLINK is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BioStav,a.s. CIN: 49437704 , Czech Republic, Active | Nov 24, 1993 | - | - | |
CELLINK, INC. CIN: 813033020 , United States, Deadpooled | Dec 31, 1999 | - | 65 (As on Dec 31, 2022) | - |
Cellink Ab CIN: - , United States, Active | Jan 26, 2016 | $16M (As on Aug 31, 2019) | 74 (As on Dec 31, 2018) | - |
Sign up to download CELLINK's company profile
CELLINK's funding and investors
CELLINK has raised funding over 12 rounds. Its first funding round was on Oct 01, 2016. CELLINK has 3 institutional investors.
Here is the list of recent funding rounds of CELLINK:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 11, 2021 | 8339743 | Post IPO | 5971977 | 2708107 | 9590031 | 8100864 |
Jan 01, 2021 | 3981143 | Grant (prize money) | 3848721 | 1611212 | 3216486 | |
Sep 01, 2020 | 4322918 | Grant (prize money) | 8544050 | 8349403 | 3730413 |
Access funding benchmarks and valuations. Sign up today!View details of CELLINK's funding rounds and investors
CELLINK's founders and board of directors
Founder? Claim ProfileHere are the details of CELLINK's key team members:
- Erik Gatenholm: Co-Founder & CEO of CELLINK and founder of 3 other companies, Bioverse, Cellink and Cellink.
- Hector Martinez: Co-Founder & CTO of CELLINK.
- Gusten Danielsson: Co-Founder & CFO of CELLINK.
View details of CELLINK's Founder profiles and Board Members
CELLINK's employee count trend
CELLINK has 65 employees as of Dec 22. The total employee count is 86.0% more than what it was in Dec 21. Here is CELLINK's employee count trend over the years:
Uncover CELLINK's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
CELLINK's Competitors and alternates
Top competitors of CELLINK include Aspect Biosystems, Cyfuse and Allevi. Here is the list of Top 10 competitors of CELLINK, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Aspect Biosystems 2013, Vancouver (Canada), Series B | Developer of bioprinting technology and tissue therapeutics for regenerative medicine | $139M | 66/100 | |
2nd | Developer of 3D tissue engineering technology | $16.6M | 60/100 | ||
3rd | Allevi 2014, Philadelphia (United States), Acquired | Manufacturer of industrial grade 3D bioprinters and materials | $2.33M | 57/100 | |
4th |  Xlife sciences 2013, Zurich (Switzerland), Public | Developer of drugs for multiple diseases | $62.8M | - | 57/100 |
5th | Develops plant-derived collagen products for tissue repair, 3D bio-printing | $16.3M | 57/100 | ||
6th | CELLINK 2016, Boston (United States), Public | Developer of 3D bioprinters and bioinks for research purposes | - | 49/100 | |
7th | Inventia Life Science 2013, Sydney (Australia), Series B | Developer of 3D bio-printers | $50M | 54/100 | |
8th | ROKIT Healthcare 2012, Seoul (South Korea), Public | Provider of 4D bio-printer solutions for tissue regenerative | $30M | 54/100 | |
9th |  CurifyLabs 2021, Helsinki (Finland), Series A | Provider of digital 3D printing solutions for personalized medicine | $20M | 53/100 | |
10th | Provider of 3D printing pharmaceutical technology platform for drug design | $102M | 53/100 |
_1558518015405.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on CELLINK's competitors? Click here to see the top ones
CELLINK's Investments and acquisitions
CELLINK has not made any investments yet. CELLINK has made 6 acquisitions.Here is the list of latest three $acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 26, 2021 | Acquisition | 2013 | San Diego (United States) | |
May 21, 2021 | Acquisition | 2007 | Eggenstein Leopoldshafen (Germany) | |
Feb 15, 2021 | Acquisition | 2010 | Oulunsalo (Finland) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by CELLINK
Reports related to CELLINK
Here is the latest report on CELLINK's sector:
News related to CELLINK
Filter this list•
US closes $362 million loan to CelLink for vehicle wiring plantMarkLines•Apr 26, 2024•DOE, CelLink, CELLINK
•
Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting3D Printing Industry•Oct 09, 2023•CELLINK, Carcinotech
•
First Centre of Excellence for 3D bioprinting launches in IndiaBioSpectrum India•Dec 10, 2022•CELLINK
•
Titan to sell large CelLink factory to Utah real estate investor tied to Mormon ChurchThe Business Journals•Sep 30, 2022•Titan Company, CELLINK
•
•
Irish start-up Zoan is using coral to 3D-print human bone graftsSilicon Republic•May 03, 2022•Zoan BioMed, CELLINK
•
Collplant Partners with Cellink in Bid to Address $2.8bn Regenerative Breast Implant Market3D Printing Industry•Feb 23, 2022•Collplant, BICO, CELLINK
•
•
CelLink takes in $250m Series DVCJ•Feb 16, 2022•CELLINK, Whale Rock Capital Management, T. Rowe Price, Fidelity Investments and 9 others
•
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInkGlobeNewswire•Jan 10, 2022•Organovo, CELLINK
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about CELLINK
Explore our recently published companies
- OUI Medical - Dallas based, 2020 founded, Seed company
- MyuNepal - Kathmandu based, 2020 founded, Unfunded company
- So Fetch - India based, 2019 founded, Unfunded company
- CloudRCM Solutions - Park Ridge based, 2020 founded, Unfunded company
- Blitz Learning - India based, 2016 founded, Unfunded company
- Write IT Solutions - Bengaluru based, 2007 founded, Unfunded company
